Chargement en cours...

Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension

Although inhaled NO (iNO) therapy is often effective in treating infants with persistent pulmonary hypertension of the newborn (PPHN), up to 40% of patients fail to respond, which may be partly due to abnormal expression and function of soluble guanylate cyclase (sGC). To determine whether altered s...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chester, Marc, Seedorf, Gregory, Tourneux, Pierre, Gien, Jason, Tseng, Nancy, Grover, Theresa, Wright, Jason, Stasch, Johannes-Peter, Abman, Steven H.
Format: Artigo
Langue:Inglês
Publié: American Physiological Society 2011
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3213988/
https://ncbi.nlm.nih.gov/pubmed/21856817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00138.2010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!